Category Archives: Cardiovascular

Smartwatch Data Plus Digital Twin Framework Predicts Risk of Heart Disease and Heart Attack

Credit: wildpixel / iStock Biomedical engineers from Duke University report they have developed a method that combines smartwatch data with a digital twin framework that can predict a patient’s risk of developing heart disease or having a heart attack. The method can digitally mimic an entire week’s worth of an individual’s heartbeat, far eclipsing previous […]

Recent scientific studies offer insight into heart and stroke health

The American Heart Association summarizes new, key findings from its annual scientific meetings that could help people with cardiovascular disease DALLAS, Nov. 28, 2023 — More than 4,000 abstracts were presented during the American Heart Association’s Scientific Sessions 2023 and Resuscitation Science Symposium 2023, held earlier this month in Philadelphia. Here are some of the […]

Bristol-Myers (NYSE:BMY) Expands Cardiovascular Collaboration with Avidity Bio (NASDAQ:RNA) in $2.3B Deal

Shares of biopharmaceutical major Bristol-Myers Squibb (NYSE:BMY) are ticking marginally higher today after the company expanded its partnership with Avidity Biosciences (NASDAQ:RNA) in a $2.3 billion deal. This development has pushed Avidity shares nearly 25% higher in the morning session already. This global licensing and research collaboration will focus on bringing up to five cardiovascular […]

Cannabis Use Disorder Substantially Increases Risk for Cardiovascular Events

Individuals with cannabis use disorder (CUD) have an approximately 60% higher risk of experiencing incident adverse cardiovascular disease (CVD) events relative to those without CUD, according to study findings published in Addiction. Cannabis use has increasingly been associated with a wide range of adverse health outcomes. Particularly, there has been an appreciable amount of research […]

Long-Term ADHD Treatment Linked to Cardiovascular Disease

Karolinska Institutet A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year. However, people who use ADHD medicine for a long time and in higher-than-average doses seem to have a higher risk of some cardiovascular diseases. This is according to two new studies led by researchers from […]

Do Sleep Disorders Have an Effect on Cardiovascular Health Outcomes?

Insomnia, narcolepsy, and sleep apnea affect cardiovascular health, according to the findings of a systematic review published in the journal Cureus. The predominant cause of mortality worldwide is noncommunicable diseases (NCDs), in which NCDs contribute to 71% of all deaths. The most common NCD is cardiovascular disease (CVD) and among the CVD population, over 70% […]

10 Most Popular Red Yeast Rice Supplements for 2023

Our Top Picks Red yeast rice supplements have gained popularity due to their potential benefits in promoting heart health and lowering cholesterol levels. With so many products available in the market, it can be challenging to determine which one is right for you. This article covers essential criteria such as dosage, potency, purity, and manufacturing […]

The Impact of GLP-1s on Cardiovascular Clinical Development, Upcoming Webinar Hosted by Xtalks

The panel will consider efforts to diversify clinical trials in the cardiovascular space and explore what else should be done to meet this need. Post this The featured speakers will also discuss the increasing moral, scientific and regulatory requirements to increase access to cardiovascular clinical trials for populations historically underserved by the clinical research community […]

Hypertension: Could long-term use of ADHD meds increase risk?

Share on PinterestUsing certain ADHD medications may be associated with an increased risk of heart disease. Raymond Forbes LLC/Stocksy Attention deficit hyperactivity disorder (ADHD) is a developmental condition that may make it harder for people to stay focused and make impulsive behaviors more likely. Some people with ADHD may benefit from taking medications that help […]

Bristol Myers bets $100M on Avidity’s RNA therapies for cardiovascular diseases

Bris­tol My­ers Squibb is fur­ther tap­ping in­to Avid­i­ty Bio­sciences for $100 mil­lion up­front to work on up to five car­dio­vas­cu­lar tar­gets. The Big Phar­ma wants more of the San Diego biotech’s RNA ther­a­peu­tic work for its car­dio­vas­cu­lar pipeline and is will­ing to dole out $60 mil­lion in cash, buy $40 mil­lion of Avid­i­ty stock at […]